Pathos AI closes Series E financing led by Bristol Myers Squibb

Pathos AI, listed in NEA’s portfolio directory, announced closing its Series E led by Bristol Myers Squibb with unnamed existing investors. The release does not identify NEA’s participation in this particular round; no NEA check size or current holding is asserted.